ARPA H
Live / Applied — Third extension granted (statement of use) (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 11 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98079673
- Mark type
- Design + words
- Filed
- 11 Jul 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Thomas Dunlap
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, flyers, posters, and brochures about federally funded biomedical and scientific research on human health and human diseases
- Class 016 — Paper goods and printed matter: Printed educational and professional publications, namely, newsletters, fact sheets, flyers, posters, and brochures about federally funded biomedical and scientific research on human health and human diseases; adhesive note pads, pens, personal organizers
- Class 020 — Furniture: Plaques of epoxy resin plastic for use as awards
- Class 021 — Housewares and glass: Beverage glassware; cups and mugs; plaques of glass and crystal for use as awards
- Class 024 — Fabrics: Plastic and vinyl banners
- Class 025 — Clothing: Tops as clothing; bottoms as clothing; headwear; baseball caps and hats; jackets as clothing; polo shirts; t-shirts
- Class 035 — Advertising and business services: Promoting research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment through the support, oversight, and coordination of research projects conducted by government agencies, health departments, researchers, scientists, universities, hospitals, research foundations, and businesses; administration and management of research grants in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; promoting collaboration within the scientific, research, academic, business, and provider communities to achieve advances in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; business management of programs related to public-private partnerships in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment
- Class 036 — Insurance and financial services: Providing grants and financial support for research, development, engineering and testing in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment
- Class 041 — Education and entertainment services: Educational services, namely, organizing, arranging, and conducting conferences, seminars, webinars, and trainings in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment, and distribution of training materials in connection therewith
- Class 042 — Scientific and technological services: Biomedical research services; Research and development, engineering, and product testing services in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; medical and scientific research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; technological research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; technical research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; providing medical research, biomedical research, and scientific research information in the fields of in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; providing medical research, biomedical research, and scientific research information in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment via a global internet website
Owner
- U.S. Department of Health and Human Services, Bethesda, MD, US
- U.S. Department of Health and Human Services, Bethesda, MD, US
Prosecution history
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 3 GRANTED
- 03 Mar 2026 — SOU EXTENSION 3 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 2 GRANTED
- 03 Sept 2025 — SOU EXTENSION 2 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2025 — SOU EXTENSION 1 GRANTED
- 26 Feb 2025 — SOU EXTENSION 1 FILED
- 26 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION